Video Upload Options

References

1. Corderoy, Amy (February 15, 2013). "Landmark patent ruling over breast cancer gene BRCA1". Sydney Morning Herald. http://www.smh.com.au/national/health/landmark-patent-ruling-over-breast-cancer-gene-brca1-20130215-2egsq.html. 
2. Corderoy, Amy (March 4, 2013). "BRCA1 gene patent ruling to be appealed". Sydney Morning Herald. http://www.smh.com.au/national/brca1-gene-patent-ruling-to-be-appealed-20130304-2fg1f.html. 
3. Corderoy, Amy (June 14, 2013). "Companies can't patent genes, US court rules". Sydney Morning Herald. http://www.smh.com.au/technology/sci-tech/companies-cant-patent-genes-us-court-rules-20130614-2o836.html. 
4. "Full Federal Court Upholds Gene Patents: D'Arcy v Myriad Genetics Inc [2014 FCAFC 115"]. http://www.timebase.com.au/news/2014/AT499-article.html. 
5. "Tim Vines, Thomas Faunce, Cancer Voices Australia v Myriad Genetics Inc [2013 FCA 65: Should Gene Patent Monopolies Trump Public Health?, Journal of Law and Medicine"]. https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2333294. 
6. "Genes can't be patented, rules Australia's High Court". 7 October 2015. https://www.newscientist.com/article/gene-patents-struck-down-by-australias-high-court/. 
7. Patent Act, R.S.C., 1985, c. P-4, s 2.
8. Patent Act, R.S.C., 1985, c. P-4, s 8.
9. Branch, Legislative Services (2017-09-21). "Consolidated federal laws of canada, Patented Medicines (Notice of Compliance) Regulations". https://laws-lois.justice.gc.ca/eng/regulations/sor-93-133/FullText.html. 
10. Harvard College v. Canada (Commissioner of Patents), 2002 SCC 76
11. "Bioethics and Patent Law: The Case of the Oncomouse" (in en). https://www.wipo.int/wipo_magazine/en/2006/03/article_0006.html. 
12. "Patenting Antibody-Based Biologics In Canada - Intellectual Property - Canada". https://www.mondaq.com/canada/patent/1013754/patenting-antibody-based-biologics-in-canada. 
13. Lipkus, Nathaniel (2016). "Ground Breaking Settlement Changes Landscape for genetic medicine in Canada". https://www.osler.com/en/about-us/press-room/2016/ground-breaking-settlement-changes-landscape-for-g. 
14. "Patenting in Canada: Do These Genes Fit? | Blakes" (in en). https://blakes.com/insights/articles/2016/patenting-in-canada-do-these-genes-fit. 
15. LoTempio, Vincent (2017-04-18). "Patenting DNA: Does Canada Have it Right?" (in en-US). https://www.lotempiolaw.com/2017/04/blog-2/can-patent-dna/. 
16. Ali-Khan, Sarah E.; Gold, E. Richard (November 2017). "Gene patents still alive and kicking: their impact on provision of genetic testing for long QT syndrome in the Canadian public health-care system" (in en). Genetics in Medicine 19 (11): 1253–1259. doi:10.1038/gim.2017.43. ISSN 1530-0366. PMID 28492533.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=5682567
17. Sharples, Andrew (2011-03-23). "Gene Patents in Europe Relatively Stable Despite Uncertainty in the U.S.". Genetic Engineering and Biotechnology News. http://www.genengnews.com/insight-and-intelligenceand153/gene-patents-in-europe-relatively-stable-despite-uncertainty-in-the-u-s/77899385/. 
18. Decision G2/06 of 25 November 2008, WARF/Stem Cells (OJ EPO 2009, 306). See also Decision T 2221/10 of 4 February 2014, Culturing stem cells/TECHNION. http://archive.epo.org/epo/pubs/oj009/05_09/05_3069.pdf
19. iPS Cell Technology Spurs Biological Patenting in Japan, World Intellectual Property Review, May 2013, http://sugi.pat.co.jp/wp-content/uploads/2013/05/WIPR-2013-Annual_Page_1.pdf, retrieved 2013-08-06 
20. "Guest Post: Myriad Misunderstanding of Parke-Davis v. Mulford". 23 May 2012. https://patentlyo.com/patent/2012/05/myriad-parke-davis.html. 
21. "Why People with Diabetes Can't Buy Generic Insulin". 18 Mar 2015. http://www.hopkinsmedicine.org/news/media/releases/why_people_with_diabetes_cant_buy_generic_insulin. 
22. "Gene Patenting Debate Continues". 9 Jun 2009. http://www.patentdocs.org/2009/06/gene-patenting-debate-continues.html. 
23. "Patents in Genomics and Human Genetics". Annu Rev Genom Hum Genet 11: 383–425. 22 Sep 2010. doi:10.1146/annurev-genom-082509-141811. PMID 20590431.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2935940
24. Association for Molecular Pathology v. Myriad Genetics, 569 U.S. ___ (2013) [1]
25. Cook-Deegan, Robert; MD. "Gene Patents" (in en-US). https://www.thehastingscenter.org/briefingbook/gene-patents/. 
26. Dresser R. 1988. Ethical and Legal Issues in Patenting New Animal Life. Jurimetrics 28:399-435
27. Marchant GE. 2007. Genomics, Ethics, and Intellectual Property. Intellectual Property Management in Health and Agricultural Innovation: A Handbook of Best Practices. Ch 1.5:29-38
28. Andrews, LB (2000). "Genes and Patent Policy: Rethinking IP Rights". Nature Reviews Genetics 3 (10): 803–8. doi:10.1038/nrg909. PMID 12360238.  https://dx.doi.org/10.1038%2Fnrg909
29. "Gene Patenting". http://www.ama-assn.org/ama/pub/physician-resources/medical-science/genetics-molecular-medicine/related-policy-topics/gene-patenting.page?. 
30. Caulfield, TA; Gold, ER (2000). "Genetic Testing. Ethical Concerns, and the Role of Patent Law". Clinical Genetics 57 (5): 370–75. doi:10.1034/j.1399-0004.2000.570507.x. PMID 10852371.  https://dx.doi.org/10.1034%2Fj.1399-0004.2000.570507.x
31. Reighman, J (1995). "Universal Minimum Standards of Intellectual Property Protection under the TRIPS Component of the WTO Agreement". The International Lawyer 29: 345. https://scholar.smu.edu/cgi/viewcontent.cgi?article=3106&context=til. 
32. King, Mike (2020-08-03). "Patents, private governance and access to vaccines and treatments for Covid-19" (in en-US). https://blogs.bmj.com/medical-ethics/2020/08/04/patents-private-governance-access-to-vaccines-and-treatments-for-covid-19/. 
33. "Is a vaccine a private patent or a global public good?". Christian Science Monitor. 2021-03-01. ISSN 0882-7729. https://www.csmonitor.com/World/2021/0301/Is-a-vaccine-a-private-patent-or-a-global-public-good. 
34. "WHO Director-General's opening remarks at the media briefing on COVID-19 - 6 April 2020" (in en). https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---6-april-2020. 
35. "Is a vaccine a private patent or a global public good?". Christian Science Monitor. 2021-03-01. ISSN 0882-7729. https://www.csmonitor.com/World/2021/0301/Is-a-vaccine-a-private-patent-or-a-global-public-good. 
36. Zohny, Hazem (2020-04-16). "Covid-19, Patents & Healthcare: The Need for A (Bio)ethics Space within Patent Law" (in en-US). https://blogs.bmj.com/medical-ethics/2020/04/16/covid-19-patents-healthcare-the-need-for-a-bioethics-space-within-patent-law/. 
37. "The key covid-19 compulsory licensing developments so far | IAM" (in en). https://www.iam-media.com/coronavirus/the-key-covid-19-compulsory-licensing-developments-so-far. 
38. "Vaccines and patents: how self-interest and artificial scarcity weaken human solidarity". 2021-02-09. https://blogs.lse.ac.uk/politicsandpolicy/vaccines-and-patents/. 
39. Zohny, Hazem (2020-04-16). "Covid-19, Patents & Healthcare: The Need for A (Bio)ethics Space within Patent Law" (in en-US). https://blogs.bmj.com/medical-ethics/2020/04/16/covid-19-patents-healthcare-the-need-for-a-bioethics-space-within-patent-law/.